🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07508943
Starting soon Observational

Decision-making and Optimization of Ventilatory Support for AECOPD Patients

NCT07508943 · tracked via the Priya Life Science China tracker
Sponsor
Sir Run Run Shaw Hospital
Phase
Observational
Started
2026-03-18
Last updated
2026-04-02

Condition(s) studied

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Study summary

The goal of this retrospective observational study is to learn about how respiratory support is selected and adjusted in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The main questions it aims to answer are:

1. How are different respiratory support modalities selected for patients with AECOPD in real-world practice?
2. What clinical patterns are associated with escalation, de-escalation, switching, or discontinuation of respiratory support during hospitalization? Researchers will review de-identified hospital records of patients admitted with AECOPD and analyze the dynamic use of respiratory support during hospitalization, including conventional oxygen therapy, high-flow nasal cannula oxygen therapy, non-invasive ventilation, and invasive mechanical ventilation.

Participants will not receive any study-assigned intervention. The study will use existing clinical data collected during routine inpatient care and will not change diagnosis, treatment, or follow-up.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: * Hospitalized patients with a documented diagnosis of acute exacerbation of chronic obstructive pulmonary disease. * Patients identified retrospectively from hospital records during the predefined study period. * Patients who received at least one form of respiratory support during the index hospitalization, including conventional oxygen therapy, high-flow nasal cannula oxygen therapy, noninvasive ventilation, or invasive mechanical ventilation. * Patients with available clinical records containing sufficient dynamic physiological, laboratory, and treatment-related data for retrospective analysis. Exclusion Criteria: • Patients whose hospitalization was not primarily due to acute exacerbation of COPD, even if COPD was documented as a comorbidity. Patients with stable COPD and no evidence of acute exacerbation during the index hospitalization. * Patients admitted primarily for other acute conditions, including but not limited to pneumonia without documented AECOPD, acute heart failure, pulmonary embolism, pneumothorax, asthma exacerbation, trauma, or postoperative care. * Patients with insufficient documentation to confirm AECOPD as the primary reason for admission. * Patients with incomplete clinical records preventing retrospective analysis. * Repeated hospitalizations of the same patient during the study period, with only the first eligible admission included.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou Zhejiang

More Sir Run Run Shaw Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07508943 on ClinicalTrials.gov ↗ ← All trials in China